Photodynamic immunotherapy (Paligent)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NamePhotodynamic immunotherapy (Paligent)
Drug Alias NamePDIT (Procept)Photo Dynamic Immunotherapy (Procept)anticancer therapeutics (Procept)galactochitosan (Procept)PDIT
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMetastasis inhibitorsPhotosensitizersImmunostimulants
TargetsUpdating
Therapy Area/IndicationsNeoplasm MetastasisBreast NeoplasmsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesPaligent Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBinary Therapeutics IncPaligent Inc
Active IndicationsN/A
Inactive IndicationsNeoplasm MetastasisBreast NeoplasmsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A